clinical trials

Roche sets sights on Novartis, Biogen as SMA trial hits target
Roche sets sights on Novartis, Biogen as SMA trial hits target
Yahoo/Reuters
Roche
SMA
risdiplam
Biogen
Novartis
clinical trials
Flag link:
AASLD: Gilead wants to move the needle for fatty liver therapies
AASLD: Gilead wants to move the needle for fatty liver therapies
Fierce Biotech
Gilead Sciences
NASH
selonsertib
clinical trials
AASLD
Flag link:
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Fierce Biotech
Bolt Biotherapeutics
immuno-oncology
clinical trials
cancer
Flag link:
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
EP Vantage
Axsome Therapeutics
migraines
AXS-07
Kala Pharmaceuticals
clinical trials
KP-121
dry eye disease
Flag link:
AnaptysBio shares collapse after 'worst case scenario' for key drug
AnaptysBio shares collapse after 'worst case scenario' for key drug
Biopharma Dive
AnaptysBio
etokimab
clinical trials
Flag link:
Takeda scores a win for Ninlaro as it aims to pioneer 'switch' maintenance in multiple myeloma
Takeda scores a win for Ninlaro as it aims to pioneer 'switch' maintenance in multiple myeloma
Fierce Pharma
Takeda
Ninlaro
Multiple Myeloma
clinical trials
Flag link:
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Marketwatch
Merck KGaA
Pfizer
Bavencio
clinical trials
gastric cancer
Flag link:
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Endpoints
Daiichi Sankyo
Exelixis
clinical trials
diabetic nephropathy
Minnebro
Flag link:
Here's Why Seattle Genetics Stock Jumped 25.7% in October
Here's Why Seattle Genetics Stock Jumped 25.7% in October
Motley Fool
Seattle Genetics
breast cancer
advanced breast cancer
clinical trials
tucatinib
Flag link:
Early data on Takeda's dengue vaccine is promising, but wait for the full dataset
Early data on Takeda's dengue vaccine is promising, but wait for the full dataset
Endpoints
Takeda
vaccines
dengue
clinical trials
Flag link:
Takeda's dengue shot 80% effective in massive phase 3 test
Takeda's dengue shot 80% effective in massive phase 3 test
Fierce Pharma
Takeda
dengue
vaccines
Sanofi
clinical trials
Flag link:
Tardy marketing application filing, trial failure troubles Supernus investors
Tardy marketing application filing, trial failure troubles Supernus investors
Endpoints
Supernus
earnings
ADHD
SPN-812
SPN-810
clinical trials
Flag link:
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut
Xconomy
Halozyme Therapeutics
pancreatic cancer
clinical trials
restructuring
layoffs
PEGPH20
Flag link:
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Endpoints
Sanofi
clinical trials
type 1 diabetes
insulin
Toujeo
Flag link:
Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute
Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute
Pharmaceutical Business Review
Daiichi Sankyo
Sarah Cannon Research Institute
antibody-drug conjugate
DS-7300
clinical trials
solid tumors
Flag link:
Novartis Admits to ‘Mistake’ After Partial Clinical Hold Placed on Zolgensma Trial
Novartis Admits to ‘Mistake’ After Partial Clinical Hold Placed on Zolgensma Trial
RAPS.org
Novartis
Zolgensma
clinical trials
SMA
FDA
Flag link:
With 2 Failed Trials, Cyclerion Announces Plans to Cut 30 Out of 135 Jobs
With 2 Failed Trials, Cyclerion Announces Plans to Cut 30 Out of 135 Jobs
BioSpace
Cyclerion
clinical trials
praliciguat
diabetic neuropathy
layoffs
Flag link:
Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns
Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns
Stat
Novartis
Zolgensma
FDA
gene therapy
clinical trials
SMA
Flag link:
Sanifit's calcification drug hits goal in renal disease phase 2b
Sanifit's calcification drug hits goal in renal disease phase 2b
Fierce Biotech
Sanfit
SNF472
clinical trials
renal disease
Flag link:
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Yahoo/Guru Focus
Biogen
Alzheimer's disease
aducanumab
clinical trials
drug development
Flag link:

Pages